The Council to Advance Human Health (CAHH) was developed as a catalyst for a focused model of translation, providing small, targeted grants for investigators to develop promising projects toward an exit. Eligible investigators are invited to present their projects to obtain funding of up to $75,000.
Some spinouts from CAHH include:
Convelo Therapeutics, Inc.
Luminary Therapeutics, Inc.
Tevard Biosciences
Read about Tevard: